INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION

摘要

The present invention relates to a pharmaceutical composition comprising (a) lixisenatide and/or a pharmaceutically acceptable salt thereof, and (b) insulin glargine and/or a pharmaceutically acceptable salt thereof, wherein the compound (b ) And compound (a) exist in a fixed ratio.